Jeff ShapiroPartner at King & SpaldingSpeaker
Profile
Jeff has 30 years’ experience in US medical device law and regulation. He counsels firms in regulatory strategy and filings, including presubmissions, clearances, approvals, and breakthrough designations. He helps European firms, among others, to develop a sound regulatory strategy for bringing their medical devices through US FDA review, to draft the relevant submissions, and to respond to FDA’s requests for information and data. When advising start-ups and mid-sized manufacturers, Jeffrey recognizes the business considerations involved in creating regulatory strategies and managing compliance. His mission is to bring companies through the FDA process as efficiently and expeditiously as possible. Jeffrey also counsels companies on post-market compliance, such as reporting to FDA, complying with the quality system regulation, labeling and advertising compliance, recalls, inspections, and warning letters, and he is an expert in FDA’s regulation of combination products (e.g., drug-device combinations).
Agenda Sessions
Chairperson’s Opening Remarks: Regulatory Affairs in Global Markets: US Region
, 08:30View SessionOverview of US FDA Regulation of Medical Devices
, 08:40View SessionPrimary Routes to US Market
, 09:00View SessionA Closer Look at Premarket Notifications and De Novo Requests
, 09:30View SessionA Closer Look at Premarket Approval (PMA) Applications
, 10:30View SessionMaking The Most of Q-Submissions
, 11:10View SessionGeneral Postmarket Requirements
, 11:55View SessionChairperson’s Afternoon Remarks: Regulatory Affairs in Global Markets: US Region
, 13:55View Session